Andelen af forsøgspersoner med behandlingssvigt var 84% (16/ 19 forsøgspersoner) i placeboarmen og 58% (11/ 19 forsøgspersoner) i lamotrigin- armen.
The proportion of subjects with treatment failure was 84% (16/ 19 subjects) in the placebo arm and 58% (11/ 19 subjects) in the lamotrigine arm.